• Nelya Melnitchouk Department of Surgery, Brigham and Woman’s Hospital, Harvard Medical School
  • Galyna Shabat Department of Surgery, Brigham and Woman’s Hospital, Harvard Medical School
Keywords: colorectal cancer; screening; Markov model; cost effectiveness.


The incidence of colorectal cancer (CRC) is increasing worldwide and it is the second most common cause of cancer death. There is a lot of investigations and improvement to rise quality of early diagnosis, successful treatment and effective preventions of colorectal cancer. Nowadays available few guidelines of international and national organizations what support effectiveness of screening programs. Colorectal cancer screening is effective way to decrease incidence and mortality with strong evidence confirmed by a lot of investigations of different scientific groups. Currently, Ukraine doesn’t have an established colorectal cancer program, what need to be changed as soon as possible. A lot of patients in Ukraine wait at home till the beginning of clinical symptoms, what often is the representation of later stage of diseases; and of course treatment of patients with later stage of diseases need more costs for treatment and show worst results of morbidity and mortality rate compare with patients treated at the early stage of diseases. We created a simulation Markov model and demonstrated that the implementation of the national screening program for colorectal cancer in Ukraine will be cost saving and will decrease the mortality from colorectal cancer significantly.


Download data is not yet available.


Mykhailovych Yu. I., Zvirych V. V., Kolesnik O. O. «Kolorektalnyi skryninh» yak konsensusne vyrishennia problemy mistsevoposhyrenoho raku tovstoi ta priamoi kyshky v Ukraini. Dyskusiia i pytannia // Klinichna onkolohiia. – 2017. – Vyp. 28, № 4. – Р. 16–23.

Fedorenko Z. P., Mykhailovych Yu. Y., Hulak L. O. ta in. Rak v Ukraini, 2015–2016. Zakhvoriuvanist, smertnist, pokaznyky diialnosti onkolohichnoi sluzhby // Biul. Nats. kantser-reiestru Ukrainy. – 2017. – Р. 130.

De Angelis R., Sant M., Coleman M. P. et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5-a population-based study // Lancet Oncol. – 2014. – Vol. 15, N 1. – P. 23–34.

Fitzmaurice C, Allen C., Barber R. M. et al. Global Burden of Disease Cancer. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study // JAMA Oncol. – 2017. – Vol. 4, N 3. – P. 524–548.

Frazier A. L., Colditz G. A., Fuchs C. S. et al. Cost-effectiveness of screening for colorectal cancer in the general population // JAMA. – 2000. – Vol. 284, N 15. – P. 1954–1961.

Lansdorp-Vogelaar I., Knudsen A. B., Brenner H. Cost-effectiveness of colorectal cancer screening // Epidemiol. Rev. – 2011. – Vol. 33. – P. 88–100.

Lieberman D. A., Weiss D. G., Veterans G. Affairs Cooperative Study. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon // N. Engl. J. Med. – 2001. – Vol. 345, N 8. – P. 555–560.

Melnitchouk Nelya, Soeteman Djøra I., Davids Jennifer S. et al. Cost-effectiveness of colorectal cancer screening in Ukraine // Cost Effectiveness and Resource Allocation. – 2018. – Vol. 16, N 1. – P. 3–5.

Telford J. J., Levy A. R., Sambrook J. C. et al. The cost-effectiveness of screening for colorectal cancer // CMAJ. – 2010. – Vol. 182, N 12. – P. 1307–1313.

Abstract views: 142
PDF Downloads: 130
How to Cite
Melnitchouk, N., & Shabat, G. (2019). A VIEW ON THE PROBLEM OF INADEQUATE SCREENING OF COLORECTAL CANCER IN UKRAINE. Likars’ka Sprava, (3), 3-5. https://doi.org/10.31640/JVD.3.2019(1)
Problem article